Navigation path


Public Health (26-02-2015)

AMR to remain a priority in the EU beyond 2016

The Commission today publishes a progress report on its five year Action Plan on Antimicrobial Resistance (AMR). The report summarises the progress made under each of the 12 actions.

For example, to strengthen the promotion of the appropriate use of antimicrobials in human medicine (action 1), the EU is financing ARNA, a study to identify the drivers behind the attainment of antibiotics without a medical prescription, and the ARPEC project aiming to improve the quality of antibiotic prescribing for children.

To strengthen surveillance systems in the food chain (action 10), a Commission Implementing Decision (2013/652/EU) entered into force on 1 January 2014 which ensures harmonised monitoring systems in Europe, fosters comparability between the Member States and between the human and veterinary sectors and facilitates the monitoring of patterns of multi-drug resistance in the EU.

To strengthen the prudent use of antimicrobials (action 2) the Commission adopted in September 2014, new legislative proposals on veterinary medicines and on medicated feed that will address the threat of AMR in both areas - notably, a legal tool to preserve certain antimicrobials for human use in the veterinary medicines proposal.

For a state-of-play on the actions, read the full report and see the roadmap. Amongst the report’s conclusions is that AMR will remain a priority in the EU beyond 2016.

Also today, the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC) have published a joint Annual EU Summary Report on antimicrobial resistance (AMR) in zoonotic and indicator bacteria from humans, animals and food.

For more information: